CRY - CryoLife, Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
Total revenue
274,324
262,841
189,702
180,380
Cost of revenue
92,672
89,857
61,060
61,481
Gross profit
181,652
172,984
128,642
118,899
Operating expenses
Research development
24,432
23,098
19,461
13,446
Selling general and administrative
141,030
140,574
101,211
91,548
Total operating expenses
165,462
163,672
120,672
104,994
Operating income or loss
16,190
9,312
7,970
13,905
Interest expense
15,185
15,788
4,881
3,043
Total other income/expenses net
-3,060
-141
260
7,478
Income before tax
-1,362
-6,391
3,561
18,412
Income tax expense
-2,987
-2,586
-143
7,634
Income from continuing operations
1,625
-3,805
3,704
10,778
Net income
1,625
-3,805
3,704
10,778
Net income available to common shareholders
1,615
-3,805
3,704
10,778
Reported EPS
Basic
-
-0.10
0.11
0.33
Diluted
-
-0.10
0.11
0.32
Weighted average shares outstanding
Basic
-
36,412
33,008
31,855
Diluted
-
36,412
34,163
32,822
EBITDA
-
9,397
8,442
21,455